226 related articles for article (PubMed ID: 27243824)
21. Tissue-dependent and -independent gene expression changes in metastatic colon cancer.
Gmeiner WH; Hellmann GM; Shen P
Oncol Rep; 2008 Jan; 19(1):245-51. PubMed ID: 18097602
[TBL] [Abstract][Full Text] [Related]
22. Early signet ring cell carcinoma arising from colonic adenoma: the molecular profiling supports the adenoma-carcinoma sequence.
Bellan A; Cappellesso R; Lo Mele M; Peraro L; Balsamo L; Lanza C; Fassan M; Rugge M
Hum Pathol; 2016 Apr; 50():183-6. PubMed ID: 26997454
[TBL] [Abstract][Full Text] [Related]
23. [A study on the changes of DCC and MCC genes in colorectal carcinoma and adenoma].
Zhou Y; Zhou D; Yuan A
Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):444-6. PubMed ID: 9592313
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA profiles in colorectal carcinomas, adenomas and normal colonic mucosa: variations in miRNA expression and disease progression.
Slattery ML; Herrick JS; Pellatt DF; Stevens JR; Mullany LE; Wolff E; Hoffman MD; Samowitz WS; Wolff RK
Carcinogenesis; 2016 Mar; 37(3):245-261. PubMed ID: 26740022
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
[TBL] [Abstract][Full Text] [Related]
26. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
[TBL] [Abstract][Full Text] [Related]
27. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
[TBL] [Abstract][Full Text] [Related]
28. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
[TBL] [Abstract][Full Text] [Related]
29. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S
Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872
[TBL] [Abstract][Full Text] [Related]
30. Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells.
Chen J; Ding J; Wang Z; Zhu J; Wang X; Du J
Oncotarget; 2017 Mar; 8(12):19609-19630. PubMed ID: 28121627
[TBL] [Abstract][Full Text] [Related]
31. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
Yuan P; Sun M; Zhang J; Zhu X; Shi D
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
[TBL] [Abstract][Full Text] [Related]
32. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
Zhu H; Yu J; Zhu H; Guo Y; Feng S
World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
[TBL] [Abstract][Full Text] [Related]
33. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract][Full Text] [Related]
34. Analysis of progressively overexpressed genes in tumorigenesis of colorectal cancers using cDNA microarray.
Wang JY; Yeh CS; Tzou WS; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Lin SR
Oncol Rep; 2005 Jul; 14(1):65-72. PubMed ID: 15944769
[TBL] [Abstract][Full Text] [Related]
35. Staging of colon and rectal cancer: from endoscopy to molecular markers.
Greene FL
Surg Endosc; 2006 Apr; 20 Suppl 2():S475-8. PubMed ID: 16544060
[TBL] [Abstract][Full Text] [Related]
36. Colon cancer associated transcript-1: a novel RNA expressed in malignant and pre-malignant human tissues.
Nissan A; Stojadinovic A; Mitrani-Rosenbaum S; Halle D; Grinbaum R; Roistacher M; Bochem A; Dayanc BE; Ritter G; Gomceli I; Bostanci EB; Akoglu M; Chen YT; Old LJ; Gure AO
Int J Cancer; 2012 Apr; 130(7):1598-606. PubMed ID: 21547902
[TBL] [Abstract][Full Text] [Related]
37. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.
Kahlert C; Lerbs T; Pecqueux M; Herpel E; Hoffmeister M; Jansen L; Brenner H; Chang-Claude J; Bläker H; Kloor M; Roth W; Pilarsky C; Rahbari NN; Schölch S; Bork U; Reissfelder C; Weitz J; Aust D; Koch M
Int J Cancer; 2015 Nov; 137(9):2104-13. PubMed ID: 25951369
[TBL] [Abstract][Full Text] [Related]
39. Prognostic and predictive potential molecular biomarkers in colon cancer.
Nastase A; Pâslaru L; Niculescu AM; Ionescu M; Dumitraşcu T; Herlea V; Dima S; Gheorghe C; Lazar V; Popescu I
Chirurgia (Bucur); 2011; 106(2):177-85. PubMed ID: 21696062
[TBL] [Abstract][Full Text] [Related]
40. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
